PMDA drug package insert
タフトミン3000
PMDA OTC drug · 協和薬品工業（株） · package insert Mar 8, 2025
Key facts
| Brand names | タフトミン3000 |
|---|---|
| Companies | 製造販売元／協和薬品工業（株） |
| Product type | OTC drug |
| OTC risk class | なし |
| OTC dosage form | 液剤 |
| OTC effect category | ビタミン含有保健薬（ビタミン剤等） |
| Package insert date | Mar 8, 2025 |
| PMDA document key | 230128_J2501000022 |
| PMDA company code | 230128 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: